Sarcopenia correlates with systemic inflammation in COPD
- PMID: 28255238
- PMCID: PMC5325093
- DOI: 10.2147/COPD.S130790
Sarcopenia correlates with systemic inflammation in COPD
Abstract
Background: Muscle wasting and chronic inflammation are predominant features of patients with COPD. Systemic inflammation is associated with an accelerated decline in lung function. In this study, the prevalence of sarcopenia and the relationships between sarcopenia and systemic inflammations in patients with stable COPD were investigated.
Materials and methods: In a cross-sectional design, muscle strength and muscle mass were measured by handgrip strength (HGS) and bioelectrical impedance analysis in 80 patients with stable COPD. Patients (≥40 years old) diagnosed with COPD were recruited from outpatient clinics, and then COPD stages were classified. Sarcopenia was defined as the presence of both low muscle strength (by HGS) and low muscle mass (skeletal muscle mass index [SMMI]). Levels of circulating inflammatory biomarkers (IL-6 and high-sensitivity TNFα [hsTNFα]) were measured.
Results: Sarcopenia was prevalent in 20 (25%) patients. Patients with sarcopenia were older, had lower body mass index, and a higher percentage of cardiovascular diseases. In addition, they had significantly higher modified Medical Research Council scores and lower 6-minute walk distance than those without sarcopenia. HGS was significantly correlated with age, modified Medical Research Council score, and COPD Assessment Test scores. Both HGS and SMMI had associations with IL-6 and hsTNFα (HGS, r=-0.35, P=0.002; SMMI, r=-0.246, P=0.044) level. In multivariate analysis, old age, lower body mass index, presence of cardiovascular comorbidities, and higher hsTNFα levels were significant determinants for sarcopenia in patients with stable COPD.
Conclusion: Sarcopenia is very common in patients with stable COPD, and is associated with more severe dyspnea-scale scores and lower exercise tolerance. Systemic inflammation could be an important contributor to sarcopenia in the stable COPD population.
Keywords: COPD; handgrip strength; muscle wasting; sarcopenia; systemic inflammation.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.Int J Chron Obstruct Pulmon Dis. 2015 Aug 6;10:1553-8. doi: 10.2147/COPD.S85954. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26345641 Free PMC article.
-
Hand grip strength and chronic obstructive pulmonary disease in Korea: an analysis in KNHANES VI.Int J Chron Obstruct Pulmon Dis. 2017 Aug 4;12:2313-2321. doi: 10.2147/COPD.S142621. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28831248 Free PMC article.
-
Body Composition of Filipino Chronic Obstructive Pulmonary Disease (COPD) Patients in Relation to Their Lung Function, Exercise Capacity and Quality of Life.Int J Chron Obstruct Pulmon Dis. 2019 Dec 2;14:2759-2765. doi: 10.2147/COPD.S222809. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31819408 Free PMC article.
-
Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis.J Cachexia Sarcopenia Muscle. 2020 Oct;11(5):1164-1176. doi: 10.1002/jcsm.12600. Epub 2020 Aug 30. J Cachexia Sarcopenia Muscle. 2020. PMID: 32862514 Free PMC article. Review.
-
Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state.Ageing Res Rev. 2010 Oct;9(4):431-6. doi: 10.1016/j.arr.2010.05.005. Epub 2010 May 27. Ageing Res Rev. 2010. PMID: 20553969 Free PMC article. Review.
Cited by
-
Computed tomography-based body composition parameters can predict short-term prognosis in ulcerative colitis patients.Insights Imaging. 2024 Feb 27;15(1):60. doi: 10.1186/s13244-024-01615-w. Insights Imaging. 2024. PMID: 38411849 Free PMC article.
-
Looking at the Data on Smoking and Post-COVID-19 Syndrome-A Literature Review.J Pers Med. 2024 Jan 16;14(1):97. doi: 10.3390/jpm14010097. J Pers Med. 2024. PMID: 38248798 Free PMC article. Review.
-
Long-Term Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease with Sarcopenia.Life (Basel). 2023 Jul 26;13(8):1628. doi: 10.3390/life13081628. Life (Basel). 2023. PMID: 37629485 Free PMC article.
-
Low Skeletal Muscle Mass and Clinical Outcomes in Chronic Obstructive Pulmonary Disease.Tuberc Respir Dis (Seoul). 2023 Oct;86(4):272-283. doi: 10.4046/trd.2023.0008. Epub 2023 Aug 11. Tuberc Respir Dis (Seoul). 2023. PMID: 37582676 Free PMC article.
-
Nutritional State and COPD: Effects on Dyspnoea and Exercise Tolerance.Nutrients. 2023 Apr 6;15(7):1786. doi: 10.3390/nu15071786. Nutrients. 2023. PMID: 37049625 Free PMC article. Review.
References
-
- Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. - PubMed
-
- Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(8):867–874. - PubMed
-
- Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340(2):115–126. - PubMed
-
- Kotler DP. Cachexia. Ann Intern Med. 2000;133(8):622–634. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
